Isotretinoin is notorious for having a myriad of mucocutaneous side effects including cheilitis, xerodermia, facial erythema, pruritis, hair thinning, and brittle nails, among others. Although photosensitivity is considered to be one of the side effects of oral isotretinoin therapy, cutaneous hyperpigmentation has not, to the best of our knowledge, yet been reported as a side effect. This report presents a case of striking facial hyperpigmentation in a patient on oral isotretinoin.
Case Report
Isotretinoin is notorious for having a myriad of side effects involving several organ systems. Cheilitis is often listed as the most significant mucocutaneous adverse reaction. [1] [2] [3] Other ones such as xerodermia, facial erythema, pruritis, hair thinning, brittle nails, and epistaxis are to name but a few. 2, 3 Moreover, polymorphous erythema, pityriasis rosea-like eruptions, and urticaria are examples of uncommon allergic reactions that have been reported. 1 Other side effects include pyogenic granulomas, 4 , 5 pyoderma gangrenosum, 6 and acquired port wine stain. 7 By increasing epidermal turn-over and thinning the stratum corneum, retinoids, including isotretinoin, may rarely be associated with photosensitivity. 3, 9 This light sensitivity may cause macular erythema often manifesting in the form of facial irritant dermatitis which is often observed in patients undergoing treatment during spring or summer. 2 This could then lead to postinflammatory hyperpigmentation (PIH), which is a reactive hypermelanosis that occurs secondary to a variety of inflammatory processes including endogenous, such as acne vulgaris, or exogenous, such as phototoxic reactions. 10 However, some studies conducted on subjects taking isotretinoin revealed within-normal phototesting results and that the retinoid concentrations necessary to induce significant phototoxicity were rather One postulation is that minocycline and its derivatives form complexes with iron that deposit in the skin.
14 Another one presumes the formation of a hypersensitivity reaction to antigens. 15 Genetic factors, predisposing preexisting actinic damage, sunlight, and concomitant medications seem to be implicated too. 16 Our patient was not taking any other medications, and the negative clinical family history may make the contribution of genetic factors unlikely. Still, the findings in our patient may suggest a similar mechanism by which type I minocycline hyperpigmentation occurs.
Interestingly, a case of isotretinoin-induced pigmented purpuric dermatosis (PPD) on the lower extremities of a young adult woman has recently been reported. The clinical and pathological findings in our case were greatly similar. 16 In summary, drug-induced photosensitization could be a possibility but is unlikely to have been solely responsible for the dramatic reaction our patient experienced taking into consideration previous reports.
More importantly, the presence of hemosiderin deposits parallels a recently reported case of isotretinoin-induced 
